Discovery - University of Dundee - Online Publications

Library & Learning Centre

Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects

Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects

Research output: Contribution to journalArticle

View graph of relations

Authors

  • Vinciane Wouters
  • Nisha Limaye
  • Melanie Uebelhoer
  • Alexandre Irrthum
  • Laurence M. Boon
  • John B. Mulliken
  • Odile Enjolras
  • Eulalia Baselga
  • Jonathan Berg
  • Anne Dompmartin
  • Sten A. Ivarsson
  • Loshan Kangesu
  • Yves Lacassie
  • Jill Murphy
  • Ahmad S. Teebi
  • Anthony Penington
  • Paul Rieu
  • Miikka Vikkula

Research units

Info

Original languageEnglish
Pages414-420
Number of pages7
JournalEuropean Journal of Human Genetics
Journal publication date1 Apr 2010
Journal number4
Volume18
DOIs
StatePublished

Abstract

Mutations in the angiopoietin receptor TIE2/TEK have been identified as the cause for autosomal dominantly inherited cutaneomucosal venous malformation (VMCM). Thus far, two specific germline substitutions (R849W and Y897S), located in the kinase domain of TIE2, have been reported in five families. The mutations result in a fourfold increase in ligand-independent phosphorylation of the receptor. Here, we report 12 new families with TEK mutations. Although the phenotype is primarily characterized by small multifocal cutaneous vascular malformations, many affected members also have mucosal lesions. In addition, cardiac malformations are observed in some families. Six of the identified mutations are new, with three located in the tyrosine kinase domain, two in the kinase insert domain, and another in the carboxy terminal tail. The remaining six are R849W substitutions. Overexpression of the new mutants resulted in ligand-independent hyperphosphorylation of the receptor, suggesting this is a general feature of VMCM-causative TIE2 mutations. Moreover, variation in the level of activation demonstrates, to the best of our knowledge for the first time, that widely differing levels of chronic TIE2 hyperphosphorylation are tolerated in the heterozygous state, and are compatible with normal endothelial cell function except in the context of highly localized areas of lesion pathogenesis. © 2010 Macmillan Publishers Limited All rights reserved.

Documents

Library & Learning Centre

Contact | Accessibility | Policy